Application 206353
- Type
- NDA
- Sponsor
- BRISTOL-MYERS SQUIBB
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | EVOTAZ | ATAZANAVIR SULFATE; COBICISTAT | TABLET;ORAL | EQ 300MG BASE;150MG | Yes | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0003-3641 | EVOTAZ | atazanavir and cobicistat | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-3641 | EVOTAZ | atazanavir and cobicistat | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-3641 | EVOTAZ | atazanavir and cobicistat | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-3641 | EVOTAZ | atazanavir and cobicistat | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 0003-3641 | EVOTAZ | atazanavir and cobicistat | E.R. Squibb & Sons, L.L.C. | NDA | Current |
| 50090-1724 | EVOTAZ | atazanavir and cobicistat | A-S Medication Solutions | NDA | Current |